397 related articles for article (PubMed ID: 27339615)
1. Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature.
Gruenbaum SE; Zlotnik A; Gruenbaum BF; Hersey D; Bilotta F
CNS Drugs; 2016 Sep; 30(9):791-806. PubMed ID: 27339615
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury.
Alnemari AM; Krafcik BM; Mansour TR; Gaudin D
World Neurosurg; 2017 Oct; 106():509-528. PubMed ID: 28712906
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase inhibition with the antipterin VAS203 improves outcome in moderate and severe traumatic brain injury: a placebo-controlled randomized Phase IIa trial (NOSTRA).
Stover JF; Belli A; Boret H; Bulters D; Sahuquillo J; Schmutzhard E; Zavala E; Ungerstedt U; Schinzel R; Tegtmeier F;
J Neurotrauma; 2014 Oct; 31(19):1599-606. PubMed ID: 24831445
[TBL] [Abstract][Full Text] [Related]
4. An overview of systematic reviews on the pharmacological randomized controlled trials for reducing intracranial pressure after traumatic brain injury.
Kim S; Mortera M; Heyn PC; Sood P; Wen PS; Chen Wong D; Tanveer S; Hu X
Brain Inj; 2022 Jun; 36(7):829-840. PubMed ID: 35708261
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Randomized Controlled Trials Comparing Hypertonic Sodium Solutions and Mannitol for Traumatic Brain Injury: Implications for Emergency Department Management.
Burgess S; Abu-Laban RB; Slavik RS; Vu EN; Zed PJ
Ann Pharmacother; 2016 Apr; 50(4):291-300. PubMed ID: 26825644
[TBL] [Abstract][Full Text] [Related]
6. Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
Lerouet D; Marchand-Leroux C; Besson VC
Fundam Clin Pharmacol; 2021 Jun; 35(3):524-538. PubMed ID: 33527472
[TBL] [Abstract][Full Text] [Related]
7. Impact of intracranial pressure monitoring on mortality in patients with traumatic brain injury: a systematic review and meta-analysis.
Yuan Q; Wu X; Sun Y; Yu J; Li Z; Du Z; Mao Y; Zhou L; Hu J
J Neurosurg; 2015 Mar; 122(3):574-87. PubMed ID: 25479125
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection Trials in Traumatic Brain Injury.
Chakraborty S; Skolnick B; Narayan RK
Curr Neurol Neurosci Rep; 2016 Apr; 16(4):29. PubMed ID: 26883431
[TBL] [Abstract][Full Text] [Related]
9. A review of the neuroprotective role of vitamin D in traumatic brain injury with implications for supplementation post-concussion.
Lawrence DW; Sharma B
Brain Inj; 2016; 30(8):960-8. PubMed ID: 27185224
[TBL] [Abstract][Full Text] [Related]
10. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.
McConeghy KW; Hatton J; Hughes L; Cook AM
CNS Drugs; 2012 Jul; 26(7):613-36. PubMed ID: 22668124
[TBL] [Abstract][Full Text] [Related]
11. Does magnesium sulfate have a role in the management of severe traumatic brain injury in civilian and military populations? A systematic review and meta-analysis.
Lyons MWH; Blackshaw WJ
J R Army Med Corps; 2018 Nov; 164(6):442-449. PubMed ID: 29666199
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis.
Williamson DR; Frenette AJ; Burry L; Perreault MM; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
Syst Rev; 2016 Nov; 5(1):193. PubMed ID: 27855720
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Traumatic Brain Injury and the Impact of Antioxidant Therapy on Clinical Outcomes.
Shen Q; Hiebert JB; Hartwell J; Thimmesch AR; Pierce JD
Worldviews Evid Based Nurs; 2016 Oct; 13(5):380-389. PubMed ID: 27243770
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review.
Jae J; Li Y; Sun C; Allan A; Basmaji J; Chilton S; Simsam MH; Kao R; Owen A; Parry N; Priestap F; Rochwerg B; Smith S; Turgeon AF; Vogt K; Walser E; Iansavitchene A; Ball I
J Neuroimmune Pharmacol; 2024 Jun; 19(1):33. PubMed ID: 38900343
[TBL] [Abstract][Full Text] [Related]
15. Progesterone for Traumatic Brain Injury: A Meta-Analysis Review of Randomized Controlled Trials.
Lu XY; Sun H; Li QY; Lu PS
World Neurosurg; 2016 Jun; 90():199-210. PubMed ID: 26960278
[TBL] [Abstract][Full Text] [Related]
16. Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.
Chiu LS; Anderton RS; Knuckey NW; Meloni BP
Mol Neurobiol; 2017 Dec; 54(10):7838-7857. PubMed ID: 27844291
[TBL] [Abstract][Full Text] [Related]
17. Mortality and Outcome Comparison Between Brain Tissue Oxygen Combined with Intracranial Pressure/Cerebral Perfusion Pressure-Guided Therapy and Intracranial Pressure/Cerebral Perfusion Pressure-Guided Therapy in Traumatic Brain Injury: A Meta-Analysis.
Xie Q; Wu HB; Yan YF; Liu M; Wang ES
World Neurosurg; 2017 Apr; 100():118-127. PubMed ID: 28057593
[TBL] [Abstract][Full Text] [Related]
18. Progesterone neuroprotection: The background of clinical trial failure.
Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions in traumatic brain injury: Can we rely on systematic reviews for evidence?
Gultekin R; Huang S; Clavisi O; Pattuwage L; König TC; Gruen R
Injury; 2016 Mar; 47(3):516-24. PubMed ID: 26589595
[TBL] [Abstract][Full Text] [Related]
20. Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?
Gronbeck KR; Rodrigues CM; Mahmoudi J; Bershad EM; Ling G; Bachour SP; Divani AA
Neurocrit Care; 2016 Aug; 25(1):153-66. PubMed ID: 26759227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
